Cargando…
Allogeneic hematopoietic cell transplantation improves outcome of adults with t(6;9) acute myeloid leukemia: results from an international collaborative study
Acute myeloid leukemia (AML) with t(6;9)(p22;q34) is a distinct entity accounting for 1-2% of AML cases. A substantial proportion of these patients have a concomitant FLT3-ITD. While outcomes are dismal with intensive chemotherapy, limited evidence suggests allogeneic hematopoietic cell transplantat...
Autores principales: | Kayser, Sabine, Hills, Robert K., Luskin, Marlise R., Brunner, Andrew M., Terré, Christine, Westermann, Jörg, Menghrajani, Kamal, Shaw, Carole, Baer, Maria R., Elliott, Michelle A., Perl, Alexander E., Ráčil, Zdeněk, Mayer, Jiri, Zak, Pavel, Szotkowski, Tomas, de Botton, Stéphane, Grimwade, David, Mayer, Karin, Walter, Roland B., Krämer, Alwin, Burnett, Alan K., Ho, Anthony D., Platzbecker, Uwe, Thiede, Christian, Ehninger, Gerhard, Stone, Richard M., Röllig, Christoph, Tallman, Martin S., Estey, Elihu H., Müller-Tidow, Carsten, Russell, Nigel H., Schlenk, Richard F., Levis, Mark J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ferrata Storti Foundation
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6939530/ https://www.ncbi.nlm.nih.gov/pubmed/31004014 http://dx.doi.org/10.3324/haematol.2018.208678 |
Ejemplares similares
-
Characteristics and outcome of patients with core-binding factor acute myeloid leukemia and FLT3-ITD: results from an international collaborative study
por: Kayser, Sabine, et al.
Publicado: (2021) -
PB1840: OUTCOME OF ADULT ACUTE MYELOID LEUKEMIA PATIENTS WITH EXTRAMEDULLARY DISEASE AFTER TREATMENT WITH VENETOCLAX/HYPOMETHYLATING AGENTS
por: Kayser, Sabine, et al.
Publicado: (2023) -
Outcome of relapsed or refractory acute B-lymphoblastic leukemia patients and BCR-ABL-positive blast cell crisis of B-lymphoid lineage with extramedullary disease receiving inotuzumab ozogamicin
por: Kayser, Sabine, et al.
Publicado: (2022) -
Therapeutic Options for Patients who are not Eligible for Intensive Chemotherapy
por: Estey, Elihu
Publicado: (2013) -
Deep sequencing in CD34(+) cells from peripheral blood enables sensitive detection of measurable residual disease in AML
por: Stasik, Sebastian, et al.
Publicado: (2022)